ClinicalTrials.Veeva

Menu

What Happens to First Trimester Nuchal Translucency

University Hospital Center (CHU) logo

University Hospital Center (CHU)

Status

Completed

Conditions

Nuchal Translucency

Study type

Observational

Funder types

Other

Identifiers

NCT04541966
RECHMPL20_0479

Details and patient eligibility

About

First trimester nuchal translucency is a call point for genetic abnormalities and birth defects. Nuchal translucency varies with LCC and therefore with gestational age as described by Chung et al who created a 99th percentile curve of nuchal translucency versus LCC. The majority of centers use the 3.5 mm cutoff as the 99th percentile instead of using nuchal translucency based on LCC. The objective of this study is to compare the fate of nuchal hyperclites> = 99th p but <3.5mm versus 3.5mm. For this the investigators have studied the ultrasound and genetic abnormalities. The investigators were also interested in the pregnancy outcomes and the percentage of pregnancies in the group> = 99th p and <3.5mm that would have been sampled for a high combined risk for trisomy 21, and therefore to determine the benefit of a systematic sample. for HCN as well as the interest of performing an ACPA that would not be performed on a sample with a high risk of trisomy 21.

Enrollment

230 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

nuchal translucency> = 99th percentile

Exclusion criteria

  • multiple pregnancies

Trial design

230 participants in 2 patient groups

Nuchal translucency> = 99th percentile and <3.5mm
Description:
Nuchal translucency\> = 99th percentile and \<3.5mm
Nuchal translucency> = 3.5 mm
Description:
Nuchal translucency\> = 3.5 mm

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems